China Universal Asset Management Company’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $793K | Buy |
23,987
+236
| +1% | +$7.8K | 0.07% | 195 |
|
|
2025
Q1 | $955K | Sell |
23,751
-1,272
| -5% | -$51.1K | 0.09% | 191 |
|
|
2024
Q4 | $1.18M | Buy |
25,023
+2,393
| +11% | +$113K | 0.11% | 139 |
|
|
2024
Q3 | $1.19M | Buy |
22,630
+9,159
| +68% | +$484K | 0.13% | 128 |
|
|
2024
Q2 | $730K | Sell |
13,471
-6,299
| -32% | -$341K | 0.1% | 125 |
|
|
2024
Q1 | $1.39M | Buy |
19,770
+8,429
| +74% | +$591K | 0.18% | 104 |
|
|
2023
Q4 | $947K | Buy |
11,341
+8,878
| +360% | +$741K | 0.18% | 109 |
|
|
2023
Q3 | $72.6K | Buy |
2,463
+1,209
| +96% | +$35.6K | 0.02% | 214 |
|
|
2023
Q2 | $40.9K | Sell |
1,254
-28
| -2% | -$913 | 0.01% | 211 |
|
|
2023
Q1 | $45.1K | Buy |
1,282
+321
| +33% | +$11.3K | 0.02% | 157 |
|
|
2022
Q4 | $44K | Sell |
961
-27,087
| -97% | -$1.24M | 0.02% | 140 |
|
|
2022
Q3 | $1.36M | Buy |
+28,048
| New | +$1.36M | 0.57% | 54 |
|